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ABSTRACT Owing to their structure and function, low-density lipoproteins
(LDLs) are particularly susceptible to the oxidative modiﬁcations. To prevent
against oxidative modiﬁcation of LDL, L-carnitine, with endogenous small
water-soluble quaternary amine possessing antioxidative properties, was used.
The aim of this paper was to prove the in vitro inﬂuence of L-carnitine on
the degree of oxidative modiﬁcation of the lipid part (estimated by conjugated
dienes, lipid hydroperoxides, and malondialdehyde levels) and the protein part
(estimated by dityrosine and tryptophan levels) of LDL native and oxidized by
cooper ions. The level of lipophylic LDL antioxidant—α-tocopherol was also
measured.
Oxidation of LDL by Cu2+ enhanced lipid peroxidation. That was mani-
fested by a statistically signiﬁcant increase in the content of malondialdehyde
(threefold), conjugated dienes (up to about 30%), and lipid hydroperoxides (up
to about 50%). Cu2+ ions were also the cause of oxidative modiﬁcations of the
protein part of LDLs. It was manifested by a signiﬁcant increase in dityrosine
(by about 50%), whereas the level of tryptophan was signiﬁcantly decreased
threefold in relation to native LDL. Incubation of LDL with Cu2+ ions also
caused a signiﬁcant sixfold decrease of α-tocopherol content in oxidized LDL.
However, L-carnitine caused a decrease in the level of conjugated dienes, lipid
hydroperoxide, malondialdehyde, and dityrosine by about 20% to 30%, and a
signiﬁcant increase (by about 50%) in the content of tryptophan in comparison
withoxidativeLDLandinasmallerdegreesigniﬁcantchangeswithnativeLDL.
Additionally, L-carnitine caused a signiﬁcant twofold increase in α-tocopherol
content in oxidized LDL.
The above results indicate that L-carnitine protects the lipid as well as
protein part of LDL particles against oxidative modiﬁcations, and this natural
antioxidant might be used to prevent against diseases of oxidative origin.
KEYWORDS L-Carnitine; LDL; Lipid Peroxidation; Oxidative Stress; Protein Oxidative
Modiﬁcations; α-Tocopherol
INTRODUCTION
Lipoproteins are soluble compounds of hydrophobic lipids with plasma proteins
that enable lipid transport through blood. Low-density lipoproteins (LDLs) are rich in
cholesterol (cholesteryl esters, 42%; unestriﬁed cholesterol, 8%) and phospholipids (22%)
and are poor in triacylglyceroles (6%). An integral component of LDL is also large
hydrophobic glycoprotein-apolipoprotein B. Apolipoprotein B (apo B) occurs in several
Received 16 June 2007;
accepted 3 August 2007.
This article is not subject to United
States Copyright Laws.
Address correspondence to Elzbieta
Skrzydlewska, Department of
Inorganic and Analytical Chemistry,
Medical University of Bialystok,
Mickiewicza 2a, Box 14 15-230,
Bialystok Poland. E-mail:
skrzydle@amb.edu.pl
455plasma lipoproteins in three general forms: apoB-100, apoB-
48, and apoB-apo(a). LDLs also contain a number of water-
and lipid-soluble antioxidants, such as ascorbic acid, uric acid,
bilirubin, transferrin, albumin, tocopherols, carotenoids, and
ubiquinols (Hatta and Frei 1995).
Owing to their structure and function, LDLs are particularly
susceptible to oxidative modiﬁcations, which are observed in
the development of many diseases (Hatta and Frei 1995).
Both phospholipids and the protein part of LDLs undergo
modiﬁcations; however, phospholipids, due to the presence of
polyunsaturated fatty acids, are peroxidized particularly easily
(Hatta and Frei 1995). Primary lipid peroxidation products are
conjugated dienes, whose metabolism leads to generation of
lipid hydroperoxides. In the presence of transition metal ions,
lipid hydroperoxides can be broken down to ﬁnal products
of lipid peroxidation, particularly α,β-unsaturated aldehydes
and ketones, which easily react with proteins and DNA, and
therefore reveal toxic and mutagenic properties (Kowaltowski
andVercesi1999).OxidativedamagetotheproteinpartofLDLs
results from modiﬁcations of apoB-100, the major protein of
LDL(FreiandGaziano1993).ApoB-100mayundergooxidative
modiﬁcationsasaresultofdirectreactionofaminoacidresidues
withfreeradicalsorwithcarbonylcompounds,generatedduring
degradation of phospholipid peroxidation products, mainly
malondialdehyde and 4-hydroxynonenal (Hoff and O’Neil
1993).
It was reported that lipoprotein oxidation has been impli-
cated in the pathogenesis of atherosclerosis and that L-carnitine
is able to protect from oxidative stress related to cardiovascular
damage (Calo et al. 2006). L-Carnitine (L-3-hydroxy-4-N,N,N-
trimethylaminobutyrate) is a highly polar, water-soluble, small
quaternary amine, which may be biosynthesized by humans.
However, L-carnitine that is present in human tissues is mainly
of exogenous origin (Agarval and Said 2004). Ninety-eight
percent of the body carnitine is found in skeletal and heart
muscle (Agarval and Said 2004). The function of carnitine is
classically described to support the transport of long-chain fatty
acids across the inner mitochondrial membrane for utilization
in metabolism through β-oxidation (Matalliotakis 2000; Walter
and Schaffhauser 2000). L-Carnitine also serves a protective
role against reactive oxygen species by exerting antioxidative
properties. These properties occur as a result of scavenging for
hydroxyl radicals and inhibiting hydroxyl radical production in
the Fenton reaction system (Derin et al. 2004).
Therefore,theaimofthepresentstudyhasbeentodetermine
the inﬂuence of L-carnitine on oxidative modiﬁcation of
LDL in vitro, through measurement of concentration of suc-
cessive lipids peroxidation products—conjugated dienes, lipid
hydroperoxides, and malondialdehyde—as well as oxidative
protein modiﬁcation products—tryptophan and dityrosine.
Moreover, the inﬂuence of L-carnitine on the level of the basic
lipophylic LDL antioxidant α-tocopherol has been examined.
EXPERIMENTAL ANALYSIS
Isolation of LDL from serum
The LDL fraction was isolated from extraplacental human
serum by precipitation in the presence of heparin and man-
ganese chloride (Burstein et al. 1970). The protein content in
the LDL fraction was measured by the Lowry method (Lowry
et al. 1951).
LDL oxidation in vitro
The stock LDL solution (5.3 mg protein/mL) was diluted
by Tris-HCl buffer (ﬁnal concentration 0.2 mol/L, pH 7.4) to
obtain the concentration 150 µg protein/mL. The oxidative
modiﬁcation of LDL was initiated by addition of CuSO4
solution (ﬁnal concentration 5 µmol/L). In order to determine
the antioxidative abilities to native and oxidized LDL solution,
L-carnitine (ﬁnal concentration 100 µmol/L) was added (5
minutes after Cu2+ ions addition). The control sample was LDL
solution (150 µg protein/mL) in Tris-HCl buffer (ﬁnal concen-
tration 0.2 mol/L, pH 7.4). All samples were incubated for 1, 2,
4, 6, and 18 h at 37◦C. The levels of lipid peroxidation products
(conjugated dienes, lipid hydroperoxides, malondialdehyde) as
well as protein oxidative modiﬁcation products (dityrosine
and tryptophan) and of α-tocopherol were measured in all
samples.
Determination of conjugated dienes
In this method dienes were extracted with chloroform-
methanol mixture (2:1; v:v) and were quantitated by their
234-nm absorbance in cyclohexane, relating to cyclohexane
blank (Recknogel and Glende 1984).
Determination of lipid
hydroperoxides
Lipid hydroperoxides were determined by a sen-
sitive and speciﬁc HPLC method involving chemi-
cal conversion of 1-naphthyldiphenylphosphine into 1-
naphthyldiphenylphosphine oxide, which was injected on RP
18 column eluted by methanol-water mixture (8:2; v:v) at 35◦C.
The detection was carried at λ = 292 nm (Tokumaru et al.
1995).
Determination of malondialdehyde
(MDA) by HPLC
The procedure involves formation of MDA with thio-
barbituric acid (TBA) adducts and the separation of TBA-
MDA adducts on RP 18 column with spectroﬂuorometric
quantiﬁcation at 532 nm excitation and 553 nm emission. The
separation was carried out by mixture of 40% methanol and
60% phosphate buffer at pH 7.0 (Londero and Greco 1996).
Determination dityrosine and
tryptophan
Tryptophan and dityrosine were measured with a spec-
troﬂuorometer Hitachi 2500. Signal intensity was calibrated
against 0.1 mg/mL quinine sulfate solution in sulfuric acid
with ﬂuorescence assumed as a unit. Fluorescence emission
at 338 nm (288 nm excitation) was used as a reﬂection of
tryptophan content and dityrosine content was estimated at
325 nm excitation and 420 nm emission (Rice-Evans et al.
1991).
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FIGURE 1 The inﬂuence of L-carnitine on the content of conjugated dienes in native and oxidized LDL (n = 6). Statistically signiﬁcant
differences for p <0.05: 1 h: 1–2; 2–4; 3–4, 2 h: 1–2,3; 2–4; 3–4, 4 h: 1–2,3; 2–4; 3–4, 6 h: 1–2,3; 2–4; 3–4, 18 h: 1–2,3,4; 2–4; 3–4
Determination of α-tocopherol
by HPLC
The lipid fraction was extracted from LDL solutions by
hexane,andtheorganiclayerwasnextdriedundernitrogen.The
residue was dissolved in ethanol and injected on RP 18 column.
The separation was carried by mixture of 95% methanol and
5% water with spectrophotometric detection at 294 nm (De
Leenheer et al. 1979; Vatassery et al. 1988).
Statistical analysis
The data obtained in this study are expressed as mean ± SD.
The data were analyzed by application of standard statistical
analyses, one-way Student’s test for multiple comparisons to
determine the signiﬁcance between different groups. The values
for p <0.05 were considered as signiﬁcant.
RESULTS
Incubation of LDL with Cu2+ ions results in signiﬁcantly
enhanced lipid peroxidation. This is manifested by the sig-
niﬁcant increase in the amount of primary products of lipid
peroxidation: conjugated dienes (up to about 30%), lipid
hydroperoxides (up to about 50%), and the ﬁnal product,
malondialdehyde (threefold increase), compared to the amount
in native LDL (Figs. 1–3). The amount of above compounds
increases during 4 to 6 h incubation to be kept at the stable
level afterwards. Adding L-carnitine to the native and oxidized
LDL in solution causes in both cases a signiﬁcant decrease in
lipid peroxidation products; however, a more distinct decrease
isobservedinoxidizedLDL.UndertheinﬂuenceofL-carnitine,
the content of conjugated dienes is signiﬁcantly decreased by
about 20%, while lipid hydroperoxides and malondialdehyde
are signiﬁcantly decreased by about 30% after 6 h of incubation
in comparison with results of L-carnitine action on oxidized
LDL.
Cu2+ ions also cause an oxidative modiﬁcation of the
protein part of LDL, which is manifested by the signiﬁcant
increase in dityrosine (Fig. 4) and by the signiﬁcant decrease
in tryptophan concentration (Fig. 5). In the presence of Cu2+
ions dityrosine content increases signiﬁcantly (by about 50%)
after 4 to 6 h incubation, whereas the level of tryptophan
is signiﬁcantly decreased (threefold) in comparison to native
LDL. L-carnitine causes a statistically signiﬁcant increase in
the level of tryptophan in native LDL (by about 30%) and
in oxidized LDL (by about 50%) after 4 to 6 h incubation. The
levels of dityrosine have tendency to signiﬁcantly decrease (by
about 10%) in native and by about 20% in oxidized LDL after
L-carnitine administration.
Incubation of LDL with Cu2+ ions decreases their α-
tocopherol content (Fig. 6). The amount of α-tocopherol is
reduced signiﬁcantly throughout 6 h incubation after which it
reaches the constant value. The content of α-tocopherol in ox-
idized LDL was signiﬁcantly decreased (sixfold) in comparison
to native LDL. L-carnitine signiﬁcantly protects LDL against
a decrease in α-tocopherol concentration. L-carnitine causes a
20% increase in α-tocopherol content in native LDL, but it is
about twofold increased in oxidized LDL, in comparison to
α-tocopherol content in native and oxidized LDL treated with
L-carnitine.
DISCUSSION
The present study has conﬁrmed earlier data that Cu2+ ions
cause LDL peroxidation (Yu et al. 2004). Cu2+-directed inten-
siﬁcation of oxidative modiﬁcations of the lipid and protein
part of LDL is manifested by an increase in the concentration
of conjugated dienes, lipid hydroperoxides, malondialdehyde,
and dityrosine as well as through a decrease in the content of
tryptophan.
Oxidation of LDL by copper cations is frequently used for
in vitro studies because it imitates LDL oxidation in in vivo
conditions and copper is more potent than iron in its ability
to oxidize LDL in vitro (Roland et al. 2001). However, the
mechanisms by which metal ions stimulate LDL oxidation
457 L-Carnitine and Oxidative Modiﬁcation of LDL0
5
10
15
20
25
30
35
40
45
0 5 10 15 20
incubation time, t
L
O
O
H
 
n
m
o
l
/
m
g
 
p
r
o
t
e
i
n
LDL (1) LDL+CARN (2)
LDL+Cu(II) (3) LDL+Cu(II)+CARN (4)
FIGURE 2 The inﬂuence of L-carnitine on the content of lipid hydroperoxides in native and oxidized LDL (n = 6). Statistically signiﬁcant
differences for p <0.05: 1 h: 1–3; 2–4; 3–4, 2 h: 1–2,3; 2–4; 3–4, 4 h: 1–2,3; 2–4; 3–4, 6 h: 1–2,3;4 2–4; 3–4, 18 h: 1–2,3;4 2–4; 3–4.
are poorly understood, but two complementary mechanisms
in which copper cations are included directly in the lipid
peroxidation process or participate in oxidation of internal
LDL antioxidant—α-tocopherol to α-tocopherol radical—are
proposed (Heinecke 1999).
It is known that oxidized copper cations (Cu2+) catalyze the
decomposition of lipid hydroperoxides into alkoxyl radicals, a
potent oxidizing species (Heinecke 1999):
Cu
2++LOOH = LO
.+HO
−+Cu
+
The hydroperoxide-derived radicals may be scavenged by
antioxidants but they can also react with polyunsaturated fatty
acids (LH) to form carbon-centred radicals (L.) that initiate the
radical chain reaction of lipid peroxidation (Heinecke 1999):
LO
.+LH = LOH + L
.
The reaction cycle continues until antioxidants or
radical–radical cross-linking reactions terminate lipid
peroxidation.
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FIGURE 3 The inﬂuence of L-carnitine on the content of malondialdehyde in native and oxidized LDL (n = 6). Statistically signiﬁcant
differences for p <0.05: 1 h: 1–3,4; 2–4; 3–4, 2 h: 1–2,3,4; 2–4; 3–4, 4 h: 1–2,3,4; 2–4; 3–4, 6 h: 1–2,3,4; 2–4; 3–4, 18 h: 1–2,3,4; 2–4; 3–4.
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FIGURE 4 TheinﬂuenceofL-carnitineonthecontentofdityrosineinnativeandoxidizedLDL(n=6).Statisticallysigniﬁcantdifferences
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FIGURE 5 The inﬂuence of L-carnitine on the content of tryptophan in native and oxidized LDL (n = 6). Statistically signiﬁcant
differences for p <0.05: 1 h: 1–2,3,4; 2–4; 3–4, 2 h: 1–2,3,4; 2–4; 3–4, 4 h: 1–2,3,4; 2–4 3–4, 6 h: 1–2,3,4; 2–4; 3–4, 18 h: 1–3,4; 2–4.
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FIGURE 6 The inﬂuence of L-carnitine on the content of α-tocopherol in native and oxidized LDL (n = 6). Statistically signiﬁcant
differences for p <0.05: 1 h: 1–2,3,4; 2–4; 3–4, 2 h: 1–2,3,4; 2–4; 3–4, 4 h: 1–2,3,4; 2–4; 3–4, 6 h: 1–2,3,4; 2–4; 3–4, 18 h: 1–2,3,4; 2–4; 3–4
Another possible mechanism in which Cu2+ causes LDL ox-
idation is Cu2+ participation in the conversion of α-tocopherol
to α-tocopherol radical (Bowry and Stocker 1993; Lynch and
Frei 1995). In consequence, the α-tocopherol radical attacks a
polyunsaturated fatty acid to initiate lipid peroxidation:
α-tocopherol + Cu
2+= α-tocopherolradical + Cu
++H
+
α-tocopherolradical + LH = α-tocopherol + L
.
Reduction of Cu2+ to Cu+ by endogenous α-tocopherol
appears to be a key step in initiating LDL lipid peroxidation
(Heinecke 1999). This leads to the counterintuitive proposal
that α-tocopherol, normally considered to be an antioxidant,
can promote the peroxidation of LDL lipid part (Bowry and
Stocker 1993).
Metal ions that actively participate in the lipid peroxidation
process may be inactivated by small and large molecular
antioxidants. One such potent small molecular antioxidant
is L-carnitine produced endogenously and consumed with
food by humans. It has been proved that L-carnitine shows
an antiperoxidative effect connected with its action as a
metal chelator (Muthuswamy et al. 2006). It may chelate
transition metal ions by hydroxyl and carboxylate groups
with the complex formation (Gulcin 2006). This leads to a
decrease in metal ions concentration and in consequence to
a decreased inﬂuence of transition metal cations in free radical
generations. Independently, L-carnitine protects α-tocopherol
contained in LDL particle against oxidation by cooper
cations.
Moreover, L-carnitine has been shown to scavenge superox-
ide anion, which plays an important role in the initiation of the
formation of other ROS such as hydrogen peroxide or hydroxyl
radical, which induce oxidative damage in lipids, proteins, and
DNA (Gulcin 2006; Pietta 2000). Additionally, it has been
shown that L-carnitine also has the ability to scavenge hydrogen
peroxide and hydroxyl radical (Derin et al. 2004; Gulcin 2006).
The scavenging mechanism of L-carnitine could be explained
as follows: An abstraction of a hydrogen atom from C-2 in
the L-carnitine molecule may occur easily and in consequence
stable intermediates are generated (Gulcin 2006). The ability of
L-carnitine to scavenge hydrogen peroxide is greater than that
of trolox. The scavenging effect exerted on hydrogen peroxide
decreases in the following order: α-tocopherol > L-carnitine >
trolox (Gulcin 2006).
The protein part of LDL is subjected to oxidative modiﬁ-
cations as well. The present study has revealed that under the
inﬂuence of copper ions, the level of dityrosine is raised and
the amount of tryptophan residues is decreased. Literature data
give evidence that protein moiety of apolipoprotein B (apoB)
and its isoform apoB-100 in particular is the most susceptible
to modiﬁcations in the LDL particle (Edelstein et al. 2001).
Modiﬁcations of the protein part of LDL may exhibit oxidative
and/or covalent character. Oxidative modiﬁcations consist in a
direct oxidation of proteins by free radicals, hydroxyl radical in
particular. As a result of hydroxyl radical action, an abstraction
of a hydrogen atom from α-carbon in protein molecule occurs
and in consequence alkyl radicals (-NH-RC-CO) are formed.
Without access to oxygen, alkyl radicals can react with one
another to protein cross-link bindings formation. Oxidation
products of amino acid residues, such as cysteine and tyrosine,
mayreactwithoneanotherformingcystineordityrosinebridges
between polypeptide chains of the same or of different proteins
(Huggins et al. 1993). Also, histidine and proline residues in
LDL particles are subjected to direct oxidation by free radicals
(Yu et al. 2004). Copper ions accelerate this reaction with the
formation of a transient complex, protein (His)–Cu+, which
is a place particularly sensitive to free radical attack (Roland
et al. 2001). Moreover, phenylalanine residues may undergo
oxidativemodiﬁcationcatalyzedbycopperions,withformation
of o-tyrosine and m-tyrosine isomers and dityrosine, which do
not occur naturally (Leeuwenburgh et al. 1997). It has been
shown in this paper that L-carnitine signiﬁcantly slows down
modiﬁcation of amino acid residues (tyrosine and tryptophan)
in oxidative conditions.
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on reaction with aldehydes generated as a result of lipid
peroxidation with formation of aldehyde-protein adducts. Car-
bonyl groups formed in the above protein modiﬁcation react
particularly easily with the ε-amino group of protein lysine (Yu
et al. 2004, Nadkarni and Sayre 1995). Both aldehyde-protein
adducts and harmful products of amino acid residue oxidation
such as aspartic or glutamic acids contribute to changes in
the LDL structure (Yu et al. 2004). Oxidized LDL protein is
recognized by receptors on the surface of macrophages that
bind modiﬁed particles of LDLs, which are next absorbed by
macrophages. In this way a phagocytosis of oxidized derivatives
of LDLs contributes to the atherosclerosis development (Yang
and Koo 2000).
In living organisms L-carnitine may protect plasma LDLs
from oxidative stress by a few different mechanisms (Gulcin
2006). It is known that L-carnitine is a cofactor in the transport
of fatty acids from cytoplasm to mitochondrion, where they
are degraded by β-oxidation (Gulcin 2006). Acetyl coenzyme A
generated in this process enters the tricarboxylic acid cycle. As a
result of a large amount of oxygen consumption in β-oxidation
of fatty acids and tricarboxylic acid cycle, oxygen concentration
decreases. Thus, reactive oxygen species formation is reduced
(Mayes 2000). Moreover, L-carnitine prevents free radical
formation by inhibition of the activity of enzymes participating
intheirgenerationandbyinductionofantioxidantmechanisms
(Di Giacomo et al. 1993; Derin et al. 2004). It has been shown
that L-carnitine reduced xanthine oxidase activity and increased
the activity of superoxide dismutase, glutathione peroxidase,
and catalase (Di Giacomo et al. 1993; Derin et al. 2004). L-
carnitine has the ability to increase in the level of nonenzymatic
antioxidants such as GSH or vitamins E and C (Haripriya et al.
2005; Dayanandan et al. 2001). It was reported that L-carnitine
causes increases in vitamin E and C status by increasing the
level of GSH (Kumaran 2003; Rani and Panneerselvam 2001).
Our results provide evidence that L-carnitine is highly
effective in the prevention against LDL lipid and protein
oxidation in vitro, which is intensiﬁed in the presence of Cu2+
ions. Our results indicate one possibility to apply this natural
antioxidant in preventing diseases of oxidative origin.
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